It has been discovered that GPIIb/IIIa promotes NEU1 surface translocation and platelet desialylation in GPIIb/IIIa-containing ITP patients relies on FcγRIIA signaling on the surface of splenic macrophages rather than the platelet activation pathway (7). Here, NEU1 is linked to autoimmune thrombocytopenic purpura.